{"title":"恶性脑肿瘤的光动力疗法:过去、现在和未来","authors":"J. Akimoto","doi":"10.2530/jslsm.jslsm-41_0012","DOIUrl":null,"url":null,"abstract":"Photodynamic therapy (PDT) was approved to be covered by health insurance in Japan on 2013, as an additional intraoperative local treatment for invasive tumor cells after maximum safe resection of the primary malignant brain tumors. This review provides an overview of the clinical trials conducted over the last 40 years, illustrating how PDT is applied in the clinical practice in the world. Furthermore, examples from ongoing clinical trials are presented, and the author proposed the future perspectives of PDT for malignant brain tumors.","PeriodicalId":19350,"journal":{"name":"Nippon Laser Igakkaishi","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Photodynamic Therapy for Malignant Brain Tumors: Past, Present and Future\",\"authors\":\"J. Akimoto\",\"doi\":\"10.2530/jslsm.jslsm-41_0012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Photodynamic therapy (PDT) was approved to be covered by health insurance in Japan on 2013, as an additional intraoperative local treatment for invasive tumor cells after maximum safe resection of the primary malignant brain tumors. This review provides an overview of the clinical trials conducted over the last 40 years, illustrating how PDT is applied in the clinical practice in the world. Furthermore, examples from ongoing clinical trials are presented, and the author proposed the future perspectives of PDT for malignant brain tumors.\",\"PeriodicalId\":19350,\"journal\":{\"name\":\"Nippon Laser Igakkaishi\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nippon Laser Igakkaishi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2530/jslsm.jslsm-41_0012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nippon Laser Igakkaishi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2530/jslsm.jslsm-41_0012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Photodynamic Therapy for Malignant Brain Tumors: Past, Present and Future
Photodynamic therapy (PDT) was approved to be covered by health insurance in Japan on 2013, as an additional intraoperative local treatment for invasive tumor cells after maximum safe resection of the primary malignant brain tumors. This review provides an overview of the clinical trials conducted over the last 40 years, illustrating how PDT is applied in the clinical practice in the world. Furthermore, examples from ongoing clinical trials are presented, and the author proposed the future perspectives of PDT for malignant brain tumors.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
